Jan 8th, 2026 Miller School Researchers Pioneer Nanovanilloid-Based Brain Cooling for Traumatic Injury The Miller School team developed a nanodrug platform for targeted therapeutic hypothermia after traumatic brain injury.
Feb 19th, 2026 - 12:00 PM “Are we Destined to Repeat History ? Lessons learned from a preclinical model of smoking and vaping” VIEW EVENT DETAILS